Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYMPHONY: Rimonabant in Obese Type 2 Diabetes
NCT00478595Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Apr 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rimonabant in type 2 diabetes mellitus (T2DM), obesity, sponsored by Sanofi. Started Apr 2007; status: terminated.
02
Drugs
rimonabant
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT00478595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00478595.